They are not making big profits on this deal. Cost neutral. Basically good for advertising. Share price should rise with more exposure on the east coast. Bigger population. Bigger revenue.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025